Search

Erik A Wentzel

age ~48

from Leesburg, VA

Also known as:
  • Erik Alton Wentzel
  • Erika Wentzel
  • Eric Wentzel
  • Elizabeth Wentzel
Phone and address:
39225 Foxhill Rd, Leesburg, VA 20175
7037777500

Erik Wentzel Phones & Addresses

  • 39225 Foxhill Rd, Leesburg, VA 20175 • 7037777500
  • 375 Paddock Dr W, Savoy, IL 61874 • 2173566224
  • 308 Sorel Ct, Millersville, MD 21108 • 4109874225
  • Bowie, MD
  • Wardensville, WV
  • 39225 Foxhill Rd, Leesburg, VA 20175 • 4109874225

Work

  • Position:
    Professional/Technical

Education

  • Degree:
    High school graduate or higher

Us Patents

  • Compositions And Methods For Decreasing Microrna Expression For The Treatment Of Neoplasia

    view source
  • US Patent:
    20090209621, Aug 20, 2009
  • Filed:
    Jun 2, 2006
  • Appl. No.:
    11/921532
  • Inventors:
    Joshua T. Mendell - Baltimore MD, US
    Kathryn A. O'Donnell - Baltimore MD, US
    Karen I. Zeller - Baltimore MD, US
    Erik A. Wentzel - Millersville MD, US
    Chi V. Dang - Baltimore MD, US
  • Assignee:
    THE JOHNS HOPKINS UNIVERSITY - BALTIMORE MD
  • International Classification:
    A61K 31/7088
    C07H 21/04
    C12N 15/63
    C12N 5/00
    C12N 5/02
    C12Q 1/68
  • US Classification:
    514 44 A, 536 245, 4353201, 435325, 435375, 435 6
  • Abstract:
    The invention generally features compositions and methods that are useful for treating or diagnosing a neoplasia. The invention is based in part on the observation that c-Myc activated expression of a cluster of six miRNAs on human chromosome 13. Accordingly, the invention provides therapeutic compositions and methods for altering the expression of a microRNA of the invention thereby treating a neoplasia, as well as compositions and methods for diagnosing a neoplasia.
  • Compositions And Methods For Modulating Angiogenesis

    view source
  • US Patent:
    20100184821, Jul 22, 2010
  • Filed:
    Jul 30, 2007
  • Appl. No.:
    12/309788
  • Inventors:
    Joshua T. Mendell - Baltimore MD, US
    Erik A. Wentzel - Millersville MD, US
    Michael Dews - Haddonfield NJ, US
    Asal Homayouni - Philadelphia PA, US
  • International Classification:
    A61K 31/713
    C12N 5/07
    C12Q 1/68
    C07H 21/02
    C12N 15/63
    C12N 5/10
    A61P 9/10
    A61P 35/00
  • US Classification:
    514 44 A, 435375, 435 6, 536 245, 4353201, 435325
  • Abstract:
    The invention generally features compositions and methods that are useful for modulating angiogenesis.
  • Nucleotide Motifs Providing Localization Elements And Methods Of Use

    view source
  • US Patent:
    20100292299, Nov 18, 2010
  • Filed:
    Jun 20, 2007
  • Appl. No.:
    12/308811
  • Inventors:
    Joshua T. Mendell - Baltimore MD, US
    Erik A. Wentzel - Millersville MD, US
  • International Classification:
    A61K 31/7105
    C07H 21/02
    C12N 15/63
    A61P 43/00
  • US Classification:
    514 44 A, 536 231, 536 245, 514 44 R, 4353201
  • Abstract:
    The instant invention describes nucleotide motifs comprising a localization element and small RNA molecules comprising the localization motifs, and methods of use in gene silencing. The nucleotide motifs have use in preventing and treating diseases or disorders.
  • Compositions And Methods For Treating Hepatic Neoplasia

    view source
  • US Patent:
    20110301226, Dec 8, 2011
  • Filed:
    Dec 2, 2009
  • Appl. No.:
    13/132783
  • Inventors:
    Joshua T. Mendell - Dallas TX, US
    Kathryn A. Mendell - Baltimore MD, US
    Raghu R. Chivukula - Baltimore MD, US
    Erik A. Wentzel - Leesburg VA, US
    Jerry R. Mendell - Columbus OH, US
    K. Reed Clark - Westerville OH, US
    Janaiah Kota - Columbus OH, US
  • Assignee:
    Nationwide Children's Hospital, Inc - Columbus OH
    THE JOHNS HOPKINS UNIVERSITY - Baltimore MD
  • International Classification:
    A61K 48/00
    C12N 15/85
    C12N 15/86
    A61P 1/16
    C12N 5/10
    C12Q 1/68
    A61P 35/00
    C12N 5/09
    C12N 15/861
  • US Classification:
    514 44 R, 435375, 4353201, 435325, 435 611, 435 613
  • Abstract:
    The present invention provides compositions and methods featuring miR-26 microRNA polynucleotides for the diagnosis, treatment or prevention of hepatic neoplasia.

Resumes

Erik Wentzel Photo 1

Regional Asset Manager, Esoteric

view source
Location:
14920 Broschart Rd, Rockville, MD 20850
Industry:
Biotechnology
Work:
Quest Diagnostics
Regional Asset Manager, Esoteric

Bioreliance Apr 2016 - Dec 2016
Senior Laboratory Supervisor - Clearance Services

Covance Dec 2013 - Apr 2016
Laboratory Supervisor Ii

Covance May 2012 - Dec 2013
Research Associate Ii

Howard Hughes Medical Institute 2004 - 2011
Laboratory Manager and Research Specialist
Education:
University of Maryland - University College 2014 - 2015
Master of Business Administration, Masters, Business Administration
University of Maryland - University College 2010 - 2013
Master of Science, Masters, Management
University College 2012
Master of Science, Masters
University College 1998
Bachelors, Bachelor of Arts
Virginia Tech 1995 - 1998
Bachelor of Applied Science, Bachelors, Biology
Skills:
Continuous Process Improvement
Laboratory Quality Assurance
Cell Culture
Laboratory
Biotechnology
Rt Pcr
Qpcr
Molecular Biology
Lifesciences
Primary Cell Line Generation
Sop Writing and Testing
Glp
Tissue Culture
Cell Biology
Fluorescence Microscopy
Drug Development
Quality Management
Quality Assurance
Client Relations
Root Cause Analysis
Study Management
Viral Clearance
Genetic Anlysis
Gene Sequencing
Change Champion
Project Management
Cloning
Reporter Assays
Viral Gene Delivery
Personnel Management
Pcr
Dna
Recombinant Dna Technology
Genotyping
Dna Sequencing
Molecular Genetics
Sequencing
Transfection
Protein Expression
Elisa
Purification
Immunohistochemistry
Polymerase Chain Reaction
Life Sciences
Laboratory Skills
Good Laboratory Practice
Certifications:
Pmp
Erik Wentzel Photo 2

Erik Wentzel

view source

Googleplus

Erik Wentzel Photo 3

Erik Wentzel


Get Report for Erik A Wentzel from Leesburg, VA, age ~48
Control profile